Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Paysign, Inc. (PAYS)

Paysign Q1 2026 Revenue Rises 50.8% to $28.04 Million; Net Income Up 110.3%

Positive Impact 3 of 5 earnings Written later

Paysign reported first-quarter 2026 revenue of $28.04 million, up 50.8% from a year earlier, and net income of $5.44 million, or $0.09 per diluted share, up 110.3% from $2.59 million. The company reiterated its full-year 2026 revenue guidance of $106.5 million to $110.5 million, and said it expects to finish in the upper half of its guidance ranges.

Key points

  • Q1 2026 revenue of $28.04 million, up from $18.6 million in Q1 2025; pharma revenue rose 81.9% to $15.68 million.
  • Net income of $5.44 million, or $0.09 per diluted share, versus $2.59 million, or $0.05 per diluted share, in Q1 2025.
  • Full-year 2026 guidance reiterated: revenue of $106.5 million to $110.5 million and diluted EPS of $0.21 to $0.26; Q2 2026 revenue guidance is $26.2 million to $26.7 million.
  • Unrestricted cash was $20.55 million at March 31, 2026, with zero bank debt.

The filing

CompanyPaysign, Inc. (PAYS)
Form8-K, current report
Filed with the SECMay 12, 2026, 4:05 PM ET
Accession number0001683168-26-003722

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.